1. Home
  2. AVTX vs FNWB Comparison

AVTX vs FNWB Comparison

Compare AVTX & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • FNWB
  • Stock Information
  • Founded
  • AVTX 2011
  • FNWB 1923
  • Country
  • AVTX United States
  • FNWB United States
  • Employees
  • AVTX N/A
  • FNWB N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • FNWB Banks
  • Sector
  • AVTX Health Care
  • FNWB Finance
  • Exchange
  • AVTX Nasdaq
  • FNWB Nasdaq
  • Market Cap
  • AVTX 138.8M
  • FNWB 67.7M
  • IPO Year
  • AVTX 2015
  • FNWB 2015
  • Fundamental
  • Price
  • AVTX $11.88
  • FNWB $7.30
  • Analyst Decision
  • AVTX Strong Buy
  • FNWB Hold
  • Analyst Count
  • AVTX 9
  • FNWB 1
  • Target Price
  • AVTX $30.14
  • FNWB $12.00
  • AVG Volume (30 Days)
  • AVTX 221.6K
  • FNWB 39.7K
  • Earning Date
  • AVTX 11-06-2025
  • FNWB 10-28-2025
  • Dividend Yield
  • AVTX N/A
  • FNWB 3.78%
  • EPS Growth
  • AVTX N/A
  • FNWB N/A
  • EPS
  • AVTX N/A
  • FNWB N/A
  • Revenue
  • AVTX $441,000.00
  • FNWB $48,874,000.00
  • Revenue This Year
  • AVTX N/A
  • FNWB $34.16
  • Revenue Next Year
  • AVTX N/A
  • FNWB $11.73
  • P/E Ratio
  • AVTX N/A
  • FNWB N/A
  • Revenue Growth
  • AVTX N/A
  • FNWB N/A
  • 52 Week Low
  • AVTX $3.39
  • FNWB $6.05
  • 52 Week High
  • AVTX $16.00
  • FNWB $12.10
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 65.69
  • FNWB 43.73
  • Support Level
  • AVTX $9.54
  • FNWB $7.26
  • Resistance Level
  • AVTX $12.41
  • FNWB $7.73
  • Average True Range (ATR)
  • AVTX 1.08
  • FNWB 0.35
  • MACD
  • AVTX -0.03
  • FNWB 0.02
  • Stochastic Oscillator
  • AVTX 85.90
  • FNWB 39.02

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

Share on Social Networks: